|
Market Cap (10-Jun) $6,348,808 (1,430th) |
Close (30-Jun) $0.270 |
Volume (30-Jun) 0 |
Shortsold (2-Dec) 7,687 (0.01%) (527th) |
|
52w High $0.480 |
52w Low $0.100 |
P/E - |
EPS -0.06 |
TRP released this announcement to the ASX on 12 October 2022, 18:56. The announcement is marked as price sensitive, and is 2 page(s) in length and 213.25kb in size.
You can view all announcements from TRP and see how they appear on a price chart on the announcements page.
At the date of this announcement, TRP was 0.008% short sold according to ASIC data. It was ranked the 550th most shorted stock on the ASX. It is now ranked as the 527th most shorted stock on the ASX with 0.013% of total shares short sold as of the latest reported data (02 December 2025).
| Other Recent Announcements from TRP | |
|---|---|
| Change of Company Secretary | 28 June 2023, 18:42 |
| Change of Director's Interest Notice - JL | 6 June 2023, 18:23 |
| FDA clears TR-987 to progress to Phase 3 | 29 May 2023, 9:26 |
| TR Pro accepted for peer reviewed journal publication | 12 October 2022, 18:56 |
| Change of Company Secretary | 28 September 2022, 11:48 |
| FDA Response Clarifies Path to Phase 3 Trials | 28 September 2022, 11:33 |
| Second US Patent granted for Glucoprime | 5 September 2022, 10:00 |
You must be logged in to post a reply.
